Slc38a5 Rat 17beta-estradiol multiple interactions ISO SLC38A5 (Homo sapiens) 6480464 [Estradiol co-treated with TGFB1 protein] results in increased expression of SLC38A5 mRNA CTD PMID:30165855 Slc38a5 Rat 17beta-estradiol multiple interactions EXP 6480464 [estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of SLC38A5 mRNA CTD PMID:32741896 Slc38a5 Rat 17beta-estradiol increases expression EXP 6480464 Estradiol results in increased expression of SLC38A5 mRNA CTD PMID:32145629 Slc38a5 Rat 17beta-estradiol 3-benzoate multiple interactions EXP 6480464 [estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of SLC38A5 mRNA CTD PMID:32741896 Slc38a5 Rat 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of SLC38A5 mRNA CTD PMID:32109520 Slc38a5 Rat 2,3,7,8-Tetrachlorodibenzofuran decreases expression EXP 6480464 2,3,7,8-tetrachlorodibenzofuran results in decreased expression of SLC38A5 mRNA CTD PMID:32109520 Slc38a5 Rat 3,7-dihydropurine-6-thione decreases expression EXP 6480464 Mercaptopurine results in decreased expression of SLC38A5 mRNA CTD PMID:23358152 Slc38a5 Rat 3-isobutyl-1-methyl-7H-xanthine multiple interactions ISO SLC38A5 (Homo sapiens) 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] more ... CTD PMID:28628672 Slc38a5 Rat 4,4'-sulfonyldiphenol multiple interactions ISO SLC38A5 (Homo sapiens) 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] more ... CTD PMID:28628672 Slc38a5 Rat 4-hydroxyphenyl retinamide increases expression ISO Slc38a5 (Mus musculus) 6480464 Fenretinide results in increased expression of SLC38A5 mRNA CTD PMID:28973697 Slc38a5 Rat 4-hydroxyphenyl retinamide decreases expression ISO Slc38a5 (Mus musculus) 6480464 Fenretinide results in decreased expression of SLC38A5 mRNA CTD PMID:28973697 Slc38a5 Rat 6-propyl-2-thiouracil increases expression EXP 6480464 Propylthiouracil results in increased expression of SLC38A5 mRNA CTD PMID:24780913 Slc38a5 Rat 6-propyl-2-thiouracil decreases expression EXP 6480464 Propylthiouracil results in decreased expression of SLC38A5 mRNA CTD PMID:30047161 Slc38a5 Rat acrolein multiple interactions ISO SLC38A5 (Homo sapiens) 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of more ... CTD PMID:32699268 Slc38a5 Rat aflatoxin B1 decreases methylation ISO SLC38A5 (Homo sapiens) 6480464 Aflatoxin B1 results in decreased methylation of SLC38A5 polyA tail CTD PMID:30157460 Slc38a5 Rat all-trans-retinoic acid decreases expression ISO SLC38A5 (Homo sapiens) 6480464 Tretinoin results in decreased expression of SLC38A5 mRNA CTD PMID:33167477 Slc38a5 Rat allethrin multiple interactions EXP 6480464 [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in more ... CTD PMID:34896426 Slc38a5 Rat alpha-pinene multiple interactions ISO SLC38A5 (Homo sapiens) 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of more ... CTD PMID:32699268 Slc38a5 Rat amitrole increases expression EXP 6480464 Amitrole results in increased expression of SLC38A5 mRNA CTD PMID:38685447 Slc38a5 Rat amitrole decreases expression EXP 6480464 Amitrole results in decreased expression of SLC38A5 mRNA CTD PMID:30047161 Slc38a5 Rat ammonium chloride affects expression EXP 6480464 Ammonium Chloride affects the expression of SLC38A5 mRNA CTD PMID:16483693 Slc38a5 Rat arsenite(3-) increases methylation ISO SLC38A5 (Homo sapiens) 6480464 arsenite results in increased methylation of SLC38A5 promoter CTD PMID:23974009 Slc38a5 Rat arsenite(3-) decreases expression ISO SLC38A5 (Homo sapiens) 6480464 arsenite results in decreased expression of SLC38A5 mRNA CTD PMID:23974009 Slc38a5 Rat benzo[a]pyrene increases mutagenesis ISO SLC38A5 (Homo sapiens) 6480464 Benzo(a)pyrene results in increased mutagenesis of SLC38A5 gene CTD PMID:25435355 Slc38a5 Rat benzo[a]pyrene decreases methylation ISO SLC38A5 (Homo sapiens) 6480464 Benzo(a)pyrene results in decreased methylation of SLC38A5 3' UTR CTD PMID:27901495 Slc38a5 Rat benzo[a]pyrene increases methylation ISO SLC38A5 (Homo sapiens) 6480464 Benzo(a)pyrene results in increased methylation of SLC38A5 exon CTD PMID:27901495 Slc38a5 Rat benzo[a]pyrene affects methylation ISO SLC38A5 (Homo sapiens) 6480464 Benzo(a)pyrene affects the methylation of SLC38A5 5' UTR; Benzo(a)pyrene affects the methylation of SLC38A5 promoter CTD PMID:27901495 Slc38a5 Rat bis(2-ethylhexyl) phthalate multiple interactions ISO Slc38a5 (Mus musculus) 6480464 [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated more ... CTD PMID:31606821|PMID:39150890 Slc38a5 Rat bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of SLC38A5 mRNA CTD PMID:25181051|PMID:30816183 Slc38a5 Rat bisphenol A decreases expression ISO Slc38a5 (Mus musculus) 6480464 bisphenol A results in decreased expression of SLC38A5 mRNA CTD PMID:32156529 Slc38a5 Rat bisphenol A decreases expression ISO SLC38A5 (Homo sapiens) 6480464 bisphenol A results in decreased expression of SLC38A5 mRNA CTD PMID:33670352 Slc38a5 Rat bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of SLC38A5 mRNA CTD PMID:32145629 Slc38a5 Rat bisphenol A increases expression ISO SLC38A5 (Homo sapiens) 6480464 bisphenol A results in increased expression of SLC38A5 mRNA CTD PMID:31715268 Slc38a5 Rat bisphenol A multiple interactions ISO SLC38A5 (Homo sapiens) 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] more ... CTD PMID:28628672 Slc38a5 Rat Butylbenzyl phthalate multiple interactions ISO Slc38a5 (Mus musculus) 6480464 [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated more ... CTD PMID:39150890 Slc38a5 Rat Butylbenzyl phthalate decreases expression ISO Slc38a5 (Mus musculus) 6480464 butylbenzyl phthalate results in decreased expression of SLC38A5 mRNA CTD PMID:32308655 Slc38a5 Rat carbon nanotube decreases expression ISO Slc38a5 (Mus musculus) 6480464 Nanotubes, Carbon analog results in decreased expression of SLC38A5 mRNA; Nanotubes, Carbon results in decreased more ... CTD PMID:25554681|PMID:25620056 Slc38a5 Rat chloroprene decreases expression ISO Slc38a5 (Mus musculus) 6480464 Chloroprene results in decreased expression of SLC38A5 mRNA CTD PMID:23125180 Slc38a5 Rat choline multiple interactions ISO Slc38a5 (Mus musculus) 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased expression more ... CTD PMID:20938992 Slc38a5 Rat cisplatin multiple interactions ISO SLC38A5 (Homo sapiens) 6480464 [Cisplatin results in decreased susceptibility to Cisplatin] which results in increased expression of SLC38A5 mRNA CTD PMID:30871063 Slc38a5 Rat Cuprizon increases expression EXP 6480464 Cuprizone results in increased expression of SLC38A5 mRNA CTD PMID:26577399 Slc38a5 Rat cyhalothrin multiple interactions EXP 6480464 [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in more ... CTD PMID:34896426 Slc38a5 Rat cypermethrin multiple interactions EXP 6480464 [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in more ... CTD PMID:34896426 Slc38a5 Rat dexamethasone decreases expression ISO SLC38A5 (Homo sapiens) 6480464 Dexamethasone results in decreased expression of SLC38A5 mRNA CTD PMID:25047013 Slc38a5 Rat dexamethasone multiple interactions ISO SLC38A5 (Homo sapiens) 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] more ... CTD PMID:28628672 Slc38a5 Rat dibutyl phthalate decreases expression ISO Slc38a5 (Mus musculus) 6480464 Dibutyl Phthalate results in decreased expression of SLC38A5 mRNA CTD PMID:21266533 Slc38a5 Rat dibutyl phthalate multiple interactions ISO Slc38a5 (Mus musculus) 6480464 [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated more ... CTD PMID:39150890 Slc38a5 Rat dichloroacetic acid decreases expression ISO Slc38a5 (Mus musculus) 6480464 Dichloroacetic Acid results in decreased expression of SLC38A5 mRNA CTD PMID:28962523 Slc38a5 Rat diethyl phthalate multiple interactions ISO Slc38a5 (Mus musculus) 6480464 [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated more ... CTD PMID:39150890 Slc38a5 Rat diisobutyl phthalate multiple interactions ISO Slc38a5 (Mus musculus) 6480464 [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated more ... CTD PMID:39150890 Slc38a5 Rat diisononyl phthalate multiple interactions ISO Slc38a5 (Mus musculus) 6480464 [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated more ... CTD PMID:39150890 Slc38a5 Rat dioxygen multiple interactions ISO Slc38a5 (Mus musculus) 6480464 [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of SLC38A5 mRNA CTD PMID:30529165 Slc38a5 Rat dorsomorphin multiple interactions ISO SLC38A5 (Homo sapiens) 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression more ... CTD PMID:27188386 Slc38a5 Rat entinostat increases expression ISO SLC38A5 (Homo sapiens) 6480464 entinostat results in increased expression of SLC38A5 mRNA CTD PMID:26272509|PMID:27188386 Slc38a5 Rat entinostat multiple interactions ISO SLC38A5 (Homo sapiens) 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression more ... CTD PMID:27188386 Slc38a5 Rat ethanol decreases expression EXP 6480464 Ethanol results in decreased expression of SLC38A5 mRNA CTD PMID:20655511 Slc38a5 Rat ethyl methanesulfonate decreases expression ISO SLC38A5 (Homo sapiens) 6480464 Ethyl Methanesulfonate results in decreased expression of SLC38A5 mRNA CTD PMID:23649840 Slc38a5 Rat fenvalerate multiple interactions EXP 6480464 [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in more ... CTD PMID:34896426 Slc38a5 Rat flavonoids decreases expression EXP 6480464 Flavonoids results in decreased expression of SLC38A5 mRNA CTD PMID:18035473 Slc38a5 Rat folic acid multiple interactions ISO Slc38a5 (Mus musculus) 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased expression more ... CTD PMID:20938992 Slc38a5 Rat formaldehyde decreases expression ISO SLC38A5 (Homo sapiens) 6480464 Formaldehyde results in decreased expression of SLC38A5 mRNA CTD PMID:23649840 Slc38a5 Rat gentamycin decreases expression EXP 6480464 Gentamicins results in decreased expression of SLC38A5 mRNA CTD PMID:22061828 Slc38a5 Rat indometacin multiple interactions ISO SLC38A5 (Homo sapiens) 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] more ... CTD PMID:28628672 Slc38a5 Rat ketamine decreases expression EXP 6480464 Ketamine results in decreased expression of SLC38A5 mRNA CTD PMID:20080153 Slc38a5 Rat L-methionine multiple interactions ISO Slc38a5 (Mus musculus) 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased expression more ... CTD PMID:20938992 Slc38a5 Rat mercaptopurine decreases expression EXP 6480464 Mercaptopurine results in decreased expression of SLC38A5 mRNA CTD PMID:23358152 Slc38a5 Rat methamphetamine multiple interactions EXP 6480464 [Methamphetamine co-treated with SCH 23390] results in decreased expression of SLC38A5 mRNA CTD PMID:19564919 Slc38a5 Rat methamphetamine decreases expression EXP 6480464 Methamphetamine results in decreased expression of SLC38A5 mRNA CTD PMID:19564919 Slc38a5 Rat methimazole increases expression EXP 6480464 Methimazole results in increased expression of SLC38A5 mRNA CTD PMID:38685447 Slc38a5 Rat methimazole decreases expression EXP 6480464 Methimazole results in decreased expression of SLC38A5 mRNA CTD PMID:30047161 Slc38a5 Rat methyl methanesulfonate decreases expression ISO SLC38A5 (Homo sapiens) 6480464 Methyl Methanesulfonate results in decreased expression of SLC38A5 mRNA CTD PMID:23649840 Slc38a5 Rat mono(2-ethylhexyl) phthalate multiple interactions ISO Slc38a5 (Mus musculus) 6480464 [monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl more ... CTD PMID:39752319 Slc38a5 Rat monobenzyl phthalate multiple interactions ISO Slc38a5 (Mus musculus) 6480464 [monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl more ... CTD PMID:39752319 Slc38a5 Rat Monobutylphthalate multiple interactions ISO Slc38a5 (Mus musculus) 6480464 [monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl more ... CTD PMID:39752319 Slc38a5 Rat monoethyl phthalate multiple interactions ISO Slc38a5 (Mus musculus) 6480464 [monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl more ... CTD PMID:39752319 Slc38a5 Rat nickel sulfate decreases expression ISO SLC38A5 (Homo sapiens) 6480464 nickel sulfate results in decreased expression of SLC38A5 mRNA CTD PMID:22714537 Slc38a5 Rat oxaliplatin multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in decreased expression of SLC38A5 mRNA CTD PMID:25729387 Slc38a5 Rat oxaliplatin decreases expression EXP 6480464 oxaliplatin results in decreased expression of SLC38A5 mRNA CTD PMID:25729387 Slc38a5 Rat ozone multiple interactions ISO SLC38A5 (Homo sapiens) 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of more ... CTD PMID:32699268 Slc38a5 Rat ozone multiple interactions ISO Slc38a5 (Mus musculus) 6480464 [Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in decreased more ... CTD PMID:34911549 Slc38a5 Rat paracetamol decreases expression ISO SLC38A5 (Homo sapiens) 6480464 Acetaminophen results in decreased expression of SLC38A5 mRNA CTD PMID:22230336 Slc38a5 Rat paraquat decreases expression EXP 6480464 Paraquat results in decreased expression of SLC38A5 mRNA CTD PMID:32680482 Slc38a5 Rat pioglitazone multiple interactions ISO Slc38a5 (Mus musculus) 6480464 [N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of SLC38A5 mRNA CTD PMID:27935865 Slc38a5 Rat purine-6-thiol decreases expression EXP 6480464 Mercaptopurine results in decreased expression of SLC38A5 mRNA CTD PMID:23358152 Slc38a5 Rat pyrethrins decreases expression EXP 6480464 Pyrethrins results in decreased expression of SLC38A5 protein CTD PMID:34896426 Slc38a5 Rat quercetin increases expression ISO SLC38A5 (Homo sapiens) 6480464 Quercetin results in increased expression of SLC38A5 mRNA CTD PMID:21632981 Slc38a5 Rat SB 431542 multiple interactions ISO SLC38A5 (Homo sapiens) 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression more ... CTD PMID:27188386 Slc38a5 Rat SCH 23390 multiple interactions EXP 6480464 [Methamphetamine co-treated with SCH 23390] results in decreased expression of SLC38A5 mRNA CTD PMID:19564919 Slc38a5 Rat silicon dioxide decreases expression EXP 6480464 Silicon Dioxide results in decreased expression of SLC38A5 mRNA CTD PMID:22431001 Slc38a5 Rat sodium arsenite decreases expression ISO SLC38A5 (Homo sapiens) 6480464 sodium arsenite results in decreased expression of SLC38A5 mRNA CTD PMID:22714537 Slc38a5 Rat streptozocin increases expression ISO Slc38a5 (Mus musculus) 6480464 Streptozocin results in increased expression of SLC38A5 mRNA CTD PMID:31606821 Slc38a5 Rat streptozocin multiple interactions ISO Slc38a5 (Mus musculus) 6480464 [Streptozocin co-treated with Diethylhexyl Phthalate] results in decreased expression of SLC38A5 mRNA CTD PMID:31606821 Slc38a5 Rat sulfadimethoxine decreases expression EXP 6480464 Sulfadimethoxine results in decreased expression of SLC38A5 mRNA CTD PMID:30047161 Slc38a5 Rat tamoxifen increases expression ISO Slc38a5 (Mus musculus) 6480464 Tamoxifen results in increased expression of SLC38A5 mRNA CTD PMID:25123088 Slc38a5 Rat testosterone decreases expression ISO Slc38a5 (Mus musculus) 6480464 Testosterone deficiency results in decreased expression of SLC38A5 mRNA CTD PMID:33848595 Slc38a5 Rat testosterone multiple interactions EXP 6480464 [estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of SLC38A5 mRNA CTD PMID:32741896 Slc38a5 Rat titanium dioxide decreases expression ISO Slc38a5 (Mus musculus) 6480464 titanium dioxide results in decreased expression of SLC38A5 mRNA CTD PMID:27760801 Slc38a5 Rat toluene increases expression EXP 6480464 Toluene results in increased expression of SLC38A5 mRNA CTD PMID:22967744 Slc38a5 Rat topotecan multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in decreased expression of SLC38A5 mRNA CTD PMID:25729387 Slc38a5 Rat topotecan decreases expression EXP 6480464 Topotecan results in decreased expression of SLC38A5 mRNA CTD PMID:25729387 Slc38a5 Rat trichloroethene increases expression EXP 6480464 Trichloroethylene results in increased expression of SLC38A5 mRNA CTD PMID:33387578 Slc38a5 Rat tris(2-butoxyethyl) phosphate affects expression ISO SLC38A5 (Homo sapiens) 6480464 tris(2-butoxyethyl) phosphate affects the expression of SLC38A5 mRNA CTD PMID:29024780 Slc38a5 Rat valproic acid decreases expression EXP 6480464 Valproic Acid results in decreased expression of SLC38A5 mRNA CTD PMID:29427782 Slc38a5 Rat XL147 multiple interactions ISO Slc38a5 (Mus musculus) 6480464 [N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of SLC38A5 mRNA CTD PMID:27935865 Slc38a5 Rat zidovudine decreases expression ISO SLC38A5 (Homo sapiens) 6480464 Zidovudine results in decreased expression of SLC38A5 mRNA CTD PMID:24292225